Deutsch | Français | English

Centre National des Méningocoques
Hôpitaux Universitaires de Genève
Laboratoire de Bactériologie
Rue Gabrielle-Perret-Gentil 4
CH-1211 Genève 14

Home Publications Contacts & Links


Infections with Neisseria meningitidis are grave and present largely in two ways: as meningitis and meningococcaemia. Their case-fatality rate is high approaching 8% despite existing treatment. Preventive measures must be swiftly implemented to avoid the spread of the germ in the population. Epidemiologic surveillance by the National Centre for Meningococci (NCM) is one of the means, together with mandatory disease notification by physians and laboratories, to timely spot and fight epidemics.
NCM’s activities are carried out at the Bacteriology Laboratory of the Geneva University Hospitals. NCM has an early warning function for the Federal Office of Public Health (FOPH).

NCM’s objectives are:

  • To assist Swiss laboratories with detection of Neisseria meningitidis and to participate in the dissemination of scientific information (bacteriological identification, distribution of serogroups, methods for determining antibiotic sensitivity).
  • To monitor antibiotic resistance, particularly to penicillin. That determination is made by the MIC method (Minimum Inhibitory Concentration) and by the sequencing of the gene penA, for sensitivity to penicillin.
  • To determine serogroups (A,B,C,W135), by immunoagglutination. Certain serogroups imply specific prophylactic measures (chemoprophylaxis or vaccination for the serogroups A,C,Y,W135).
  • To identify subtypes by sequencing porA gene (encoding outer membrane proteins) or gene fetA (encoding outer membrane proteins regulated by iron).
  • To analyse additional epidemiologic markers for identification of clones: Multilocus Sequence Typing (MLST).
  • To develop techniques for more rapid diagnosis (PCR from CSF and blood) or improved genotyping of strains (biochips or microarrays).

Laboratory request form (French)

Related Links

Revised Jun 28, 2017 - © 2003-2017 Genomic Research Laboratory, Geneva